Scientific publications using CDT-CARD infrastructure

Neuroprotection by post-stroke administration of the slow-releasing hydrogen sulfide (H2S) donor AP39: Long-Term functional, MRI, and molecular evidence in a rodent stroke model

Pomierny Bartosz, Krzyżanowska Weronika, Skórkowska Alicja, Jurczyk Jakub, Przejczowska-Pomierny Katarzyna, Szafarz Małgorzata, Marcinkowska Monika, Guzda Zuzanna, Rachwał Patrycja, Kim Eugene, Mesquita Michel, Torregrossa Roberta, Whiteman Matthew, Pomierny-Chamioło Lucyna, Pera Joanna, Budziszewska Bogusława

European Journal of Pharmacology, Volume 1008, 5 December 2025, 178331, https://doi.org/10.1016/j.ejphar.2025.178331

The mitochondria-targeted hydrogen sulfide donor AP39 reduces cortical stroke volume and improves motor function in a photothrombotic stroke model in mice in a sex-dependent manner

Jakub Jurczyk, Zuzanna Guzda, Alicja Skórkowska, Żaneta Broniowska, Małgorzata Piechaczek, Aleksandra Więcek, Emilia Schulze, Angelika Ziaja, Roberta Torregrossa, Matthew Whiteman, Michel Soares Mesquita, Bartosz Pomierny, Lucyna Pomierny-Chamioło

Neuropharmacology, Volume 279, 15 November 2025, 110602, https://doi.org/10.1016/j.neuropharm.2025.110602

Neuroprotective Effects of VGLUT1 Inhibition in HT22 Cells Overexpressing VGLUT1 Under Oxygen Glucose Deprivation Conditions

B. Pomierny, W. Krzyżanowska, A. Skórkowska, B. Budziszewska,  J. Pera

NeuroMolecular Medicine (2024), Volume 26, article number 35, https://doi.org/10.1007/s12017-024-08803-3

Chicago sky blue 6B exerts neuroprotective and anti-inflammatory effects on focal cerebral ischemia

The Hydrogen Sulfide Donor AP39 Reduces Glutamate-mediated Excitotoxicity in a Rat Model of Brain Ischemia 

Inhibition of Vesicular Glutamate Transporters (VGLUTs) with Chicago Sky Blue 6B Before Focal Cerebral Ischemia Offers Neuroprotection